Steven Goldman, MD

Professor of Medicine
 
Additional Contact Info: 
Fax:  (520) 629-4636
 
Education: 
06/64 Cornell University, BA,  American Studies
06/68 University of Cincinnati, MD Medicine
07/69 University of Illinois, Intern Internal Medicine
07/70 University of Chicago, Resident Internal Medicine
07/73 Stanford University, Resident Internal Medicine
07/75 Pacific Medical Center, Fellow Cardiology
 
Honors and Awards: 
2008           Sarver Heart Center Special Service Award
2008           Founders Day Speaker University of Arizona
2009           Dean’s List for Excellence in Teaching Award-Year IV University of Arizona
2010           Keynote Speaker, VISN 17 Research Forum, Cell Based Therapy for Heart Failure, May 21, 2010
2010           Charles W. Hall, Jr.  Memorial Cardiology Fellowship Teaching Award
2013-14     Outstanding Attending of the Year, University of Arizona-Tucson Hospitals
                   Internal Medicine Residency Training Program-
2014           Teaching/Mentoring Award, University of Arizona, Cardiology Fellows
 
Selected Publications: 
Weigand K, Witte R, Moukabary T, Lancaster J, Chinyere I, Pierce MK, Goldman S. Juneman E.  In-Vivo Electrophysiological Studies in Rat Model of Chronic Ischemic Heart Failure IEEE Biomedical Transactions 2017; 64:6; 1393-1399DOI: 10.1109/TBME.2016.2605578.
 
Green JB, Bethel A, Armstrong PW et al., for the TECOS Study Group (S Goldman).  (2015).  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.  N Engl J Med 2015; 373:232-242July 16, 2015DOI: 10.1056/NEJMoa1501352
 
Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, and Emanuele NV for the VADT Investigators (S Goldman). (2015) Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes.  N Engl J Med 2015; 372:2197-2206June 4, 2015DOI: 10.1056/NEJMoa1414266.
 
O'Donoghue ML, Braunwald E, White HD, et al. TIMI 52 investigators (S Goldman).  (2014) Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial. JAMA 2014; DOI:10.1001/jama. 2014.11061.
 
Lancaster JJ, Arnce SA, Johnson NM, Juneman E, Thai H, Kellar R, Vitorin JE, Burt J, Gaballa MA, Bahl JJ, Goldman S.  2014) An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure.  Journal of Heart and Lung Transplantation 33:438-445.  http://dx.doi.org/10.1016/j.healun.2013.12.004
 
Patents: 

US Patent No: 6,534,676 B2 UA #03-075 Method to treat chronic heart failure and/or elevated cholesterol with thyroid analog (DITPA) issued 3/18/03, expiration date 5/12/21.  

US Patent No: 2002243801 Method to Treat Chronic Heart Failure and/or Elevated Cholesterol Levels using 3,5-Diiodothyropropionic Acid and Method to Prepare Same, Mexico issued 5/2/06, Australia issued 3/22/07, Canada issued 5/14/2011 

US Patent No: 7,504,435. Method for Stimulating Weight Loss and/or for Lowering Triglycerides in Patients issued 3/17/09, expiration date 4/13/2025. 

US Patent No: 8,399,518.  Administration of 3,5-Diiodothyroproprionic Acid for Stimulating Weight Loss, and/or Lowering Triglyceride Levels, and/or Treatment of Metabolic Syndrome issued March 19, 2013, expiration date 9/3/2031. 

Seeding and Co-Culture of a 3 Dimensional Fibroblast Construct (3DFC): UA/VA, UA09-061-US provisional patent serial number 61/212,280 and PCT patent application PCT/US10/30579. ssued March 2015. 

Jordan Lancaster and I have the following patents that support the IP for this grant submission. The patents have been exclusively licensed to Avery Therapeutics by the University of Arizona.

Lancaster J, Goldman S. Seeding and Co-Culture of a Three Dimensional Fibroblast Construct (3DFC): US9051550, Filed: 4-9-09, Issued: 6-9-15.

Lancaster JJ, Goldman S. Muscle cell patches and uses therefor. US0250384; Filed: 10-9-13, Issued: 6-2017.

Sponsored Research Through MSRP: 
Susan Shaw (MSRP 1982): "Control of the Peripheral Circulation in Hypertensive Dogs and Cats" 
 
Melissa Denn (MSRP 2011): "Molecular Analysis of Progenitor Cell Activity and Phenotype after Fibroblast Patch Implantation to Infarcted Tissue in Heart Failure"
 
Pablo Sanchez (MSRP 2014): "iPSC-Derived Cardiomyocycte Scaffold on Diastolic Function in Rats with Chronic Heart Failure" 
 
Chelsea Takamatsu (MSRP 2017): "Immune Response to Bioengineered Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch to Treat Heart Failure"
 
Advanced Research Distinction Track (RDT): 
Pablo Sanchez (RDT 2015): "iPSC-Derived Cardiomyocycte Scaffold on Diastolic Function in Rats with Chronic Heart Failure" 
 
NIH High School Student Research Program: 
Maria Mosqueda, Harvest Prep Academy, 2015
 
Monday, August 14, 2017